Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide

Clinical Cancer Research

Volumn 5, Issue 1, 1999, Pages 163-169

  Reese, Jane S ^a   Davis, Brian M ^a   Liu, Lili ^a   Gerson, Stanton L ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O BENZYLGUANINE; ALKYLATING AGENT; CARMUSTINE; CD34 ANTIGEN; DNA METHYLTRANSFERASE; TEMOZOLOMIDE;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; DRUG RESISTANCE; DRUG SENSITIZATION; DRUG TOLERANCE; ENZYME ACTIVITY; GENE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; COLONIC NEOPLASMS; DACARBAZINE; DRUG COMBINATIONS; DRUG RESISTANCE, NEOPLASM; GUANINE; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MICE; MICE, INBRED C3H; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; TRANSDUCTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032924967     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50: 6119-6129, 1990.
2. 6-alkylguanine-DNA alkyltransferase purified from human leukemic lymphoblasts. Cancer Res., 47: 6185-6188, 1987.
3. 6-methylguanine residues in E. coli DNA. Nature (Lond.), 296: 868-869, 1982.
4. 6-Alkylguanine DNA alkyltransferase activity correlated with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea. Proc. Natl. Acad. Sci. USA, 82: 2985-2989, 1985.
5. 6-methylguanine. Proc. Natl. Acad. Sci. USA, 79: 4786-4790, 1982.
6. 6- benzylguanine plus BCNU. Blood, 88: 1649-1655, 1996.
7. 6-alkylguanine DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis (Lond.), 7: 745-749, 1986.
8. Liu, L., Markowitz, S., and Gerson, S. L. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res., 56: 5375-5379, 1996.
9. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res., 51: 3367-3372, 1991.
10. 6-alkylguanine DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumor cells. Br. J. Cancer, 67: 1299-1302, 1993.
11. 6-benzylguanine: a comparative study in vitro. Br. J. Cancer, 73: 482-490, 1996.
12. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone. Biochem. Pharmacol., 45: 483-491, 1993.
13. 6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol., 46: 285-290, 1993.
14. 6 - benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand crosslink formation. Cancer Res., 52: 1171-1175, 1992.
15. Friedman, H. S., Dolan, M. E., Pegg, A. E., Marcelli, S., Keir, S., Catino, J. J., Bigner, D. D., and Schold, S., Jr. Activity of temozolomide in the treatment of central nervous system tumor xenografts. Cancer Res., 55: 2853-2857, 1995.
16. 6-benzylguanine. Cancer Res., 54: 6221-6227, 1994.
17. 6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea. Proc. Natl. Acad. Sci. USA, 93: 14088-14093, 1996.
18. 6-benzylguanine and BCNU. Blood, 88: 274a, 1996.
19. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res., 57: 5093-5099, 1997.
20. Ludlum, D., Kramer, B., Wang, J., and Fenselau, C. Reaction of 1,3-bis(2-chloroethyl)-1-nitrosourea with synthetic polynucleotides. Biochemistry, 14: 5480-5485, 1975.
21. Day, R., III, Ziolkowski, C., Scudiero, D., Meyer, S., and Mattern, M. Human tumor cell strains defective in the repair of alkylation damage. Carcinogenesis (Lond.), 1: 21-32, 1980.
22. Newlands, E., Stevens, M., Wedge, S., Wheelhouse, R., and Brock, C. Temozolomide: a review of its discovery, chemical properties, preclinical development and clinical trials. Cancer Treat. Rev., 23: 35-61, 1997.
23. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis (Lond.), 7: 745-749, 1986.
24. Koç, O., Gerson, S., Phillips, G., Cooper, B., Kutteh, L., Van Zant, G., Reece, D., Fox, R., Schupp, J., Tainer, N., and Lazarus, H. Autologous CD34+ cells transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment. Bone Marrow Transplant., 227: 337-343, 1998.
25. 6-benzylguanine and BCNU and remain active after high dose BG. Blood, 92: 466A, 1998.
26. 6-Alkylguanine DNA alkyltransferase activity in human myeloid cells. J. Clin. Investig., 76: 2106-2114, 1985.
27. Sorrentino, B., Brandt, S., Bodine, D., Gottesman, M., Pastan, I., Cline, A., and Nienhuis, A. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science (Washington DC), 257: 99-103, 1992.
28. Hanania, E. G., and Deisseroth, A. B. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Then, 1: 21-25, 1994.
29. Li, M-X., Banerjee, D., Zhao, S., Schweitzer, B. I., Mineishi, S., Gilboa, E., and Bertino, J. R. Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood, 83: 3403-3408, 1994.
30. Maze, R., Carney, J. P., Kelley, M. R., Glassner, B. J., Williams, D. A., and Samson, L. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. Proc. Natl. Acad. Sci. USA, 93: 206-210, 1996.
31. Moritz, T., Mackay, W., Glassner, B. J., Williams, D. A., and Samson, L. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res., 55: 2608-2614, 1995.
32. 6-benzylguanine plus BCNU. J. Clin. Oncol., in press, 1998.
33. 6-methylguanine DNA methyltransferase and chloroethylnitrosourea-treated DNA. Cancer Res., 52: 6052-6058, 1992.
34. 6-Benzylguanine potentiates in in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrow. Blood, 89: 1566-1573, 1997.
35. 6-Benzylguanine increases the sensitivity of human primary bone marrow cells to the cytotoxic effects of temozolomide. Exp. Hematol., 23: 112-116, 1995.
36. 6-benzylguanine and BCNU and allows intensive therapy of BCNU resistant xenografts in mice. Blood, 90: 243a, 1997.